CAMX:STO
Camurus AB
၆၇၁.၅၀ SEK
arrow_downward
-၀.၃၇%(-၂.၅၀) 1D
နို ၃, GMT+၁ ၁၅:၁၁:၃၁ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
၆၇၂.၀၀ SEK
High
၆၇၆.၀၀ SEK
Low
၆၆၀.၅၀ SEK
Mkt. cap
ဋေ ၄.၀၈ ထ
Avg. vol.
၈.၇၀ သောင်း
Volume
၆.၂၄ သောင်း
52-wk high
၇၁၀.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
Open
၆၇၂.၀၀ SEK
High
၆၇၆.၀၀ SEK
Low
၆၆၀.၅၀ SEK
Mkt. cap
ဋေ ၄.၀၈ ထ
Avg. vol.
၈.၇၀ သောင်း
Volume
၆.၂၄ သောင်း
52-wk high
၇၁၀.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
News stories
From web sources and news partners
FinancialContent
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
Chegg’s (NYSE:CHGG) Q3 2026: beats on revenue but quarterly revenue guidance slightly misses expectations
PR Newswire Canada
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
The Marzetti Company (NASDAQ:MZTI) misses Q3 CY2026 revenue estimates
Barchart.com
·
ပြီးခဲ့သည့် ၁ နာရီ
Upstart (NASDAQ:UPST) posts better-than-expected sales in Q3 2026, stock soars
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB